Sharekhan

Entero Healthcare Solutions Ltd

Fri 22/05/2026,15:53:44 | NSE : ENTERO

₹ 1354.4054.50 (4.19%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1319.40

Previous Close

₹ 1299.90

Volume

281929

Mkt Cap ( Rs. Cr)

₹5893.12

High

₹ 1374.00

Low

₹ 1297.50

52 Week High

₹ 1510.80

52 Week Low

₹ 944.00

Book Value Per Share

₹ 413.73

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Entero Healthcare Solutions Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

1354.40

1231

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

1231

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Entero Healthcare Solutions Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    21 May 2026, 6:20PM Intimation of Earnings call on Audited Financial Results of the Company for the quarter and year ended March 31, 2026
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    21 May 2026, 6:20PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results/Statements

    18 May 2026, 7:00PM Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to c
  • Entero Healthcare - Amalgamation/Merger

    6 May 2026, 7:31PM Entero Healthcare Solutions Limited has informed the Exchange about Amalgamation/Merger
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

    6 May 2026, 7:30PM Confirmation order sanctioning the Scheme of Amalgamation
  • Entero Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    10 Apr 2026, 5:41PM As of March 2026, 52.42% is owned by Promoters and 47.58% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 14.41% and Fore
  • Entero Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2026, 3:50PM Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Entero Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2026, 3:48PM Certificate u/r 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended March 31, 2026
  • Entero Healthcare - Trading Window

    23 Mar 2026, 5:29PM Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) R
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Change in Management

    11 Mar 2026, 8:10PM Change in Senior Management Personnel
  • Entero Healthcare - Resignation

    11 Mar 2026, 8:09PM Entero Healthcare Solutions Limited has informed the Exchange regarding Resignation of Mr. Sambit Mohanty as Senior Management Personnel of the compan
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Mar 2026, 8:04PM Intimation of Schedule of Analyst/Institutional Investor meet to be held on March 11, 2026.
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Mar 2026, 8:04PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Mar 2026, 7:51PM Intimation of Schedule of Analyst/Institutional Investor meet to be held on March 09, 2026
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Mar 2026, 7:51PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    26 Feb 2026, 7:28PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 Feb 2026, 7:27PM Intimation of Schedule of Analyst/Institutional Investor meet to be held on March 06, 2026

Key fundamentals

Evaluate the intrinsic value of Entero Healthcare Solutions Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1650.38 1626.414 675.232 581.205 486.4381
Liabilities 1650.38 1626.414 675.232 581.205 486.4381
Equity 43.508 43.494 4.112 3.85 0.1002
Gross Profit -30.346 -34.494 -43.916 -53.716 -36.9478
Net Profit 19.181 38.44 -12.455 -40.847 -18.1512
Cash From Operating Activities -109.016 -75.65 -56.909 -44.698 -68.1958
NPM(%) 4.69 12.08 -7 -29.75 -18.17
Revenue 408.67 318.161 177.69 137.286 99.8955
Expenses 439.016 352.655 221.606 191.002 136.8433
ROE(%) 1.06 2.13 -0.69 -2.26 -1

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Entero Healthcare Solutions Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 705.80 -0.07 0.00 772.13 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 109.19 1.26 352.23 2813.53 3.55 0.00
Vaishali Pharma Ltd 7.00 0.14 0.00 17650.22 3.13 0.00
Astec Lifesciences Ltd 771.80 4.77 0.00 2653.23 -363.15 0.00

Company Info

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Parent Organisation

Entero Healthcare Solutions Ltd.

Founded

10/01/2018

Managing Director

Mr.Prabhat Agrawal

NSE Symbol

ENTEROEQ

FAQ

OPEN FREE* DEMAT ACCOUNT